IP Library Assignment 054743/0862
Patent Assignment
Reel/Frame 054743/0862

Assignment of Assignor's Interest

Recorded: 2020-12-23 Pages: 3
Assignor
HENLIX BIOTECH CO., LTD.
Executed: 2020-07-26
Assignee
SHANGHAI HENLIUS BIOTECH, INC.
ROOM 303, 304, BLOCK 7, NO. 1999 ZHANGHENG ROAD, CHINA (SHANGHAI) PILOT FREE TRADE ZONE, SHANGHAI, 201210, CHINA
Covered Property (1)
Anti-Epidermal Growth Factor Receptor (Egfr) Antibodies
Application: 15/315,371 →
Publication: US 2017/0218073
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 10, 2019
From: HENLIUS BIOPHARMACEUTICALS, INC.
To: HENLIUS BIOTECH CO., LTD
Reel/Frame 051237/0566 →
Assignment of Assignor's Interest Dec 10, 2019
From: JIANG, WEI-DONG; LIN, PEI-HUA
To: HENLIUS BIOPHARMACEUTICALS, INC.
Reel/Frame 051244/0737 →
Change of Name Jan 22, 2020
From: HENLIUS BIOTECH CO., LTD.
To: HENLIX BIOTECH CO., LTD
Reel/Frame 051666/0526 →